- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Cemax-Icon plans initial public offering
One of the industry's most promising PACS companies is planningto go public. Cemax-Icon of Fremont, CA, is laying the groundworkfor issuing an initial public offering in the next several months.Company officials aren't saying much about the offering, in
One of the industry's most promising PACS companies is planningto go public. Cemax-Icon of Fremont, CA, is laying the groundworkfor issuing an initial public offering in the next several months.Company officials aren't saying much about the offering, in deferenceto the "quiet period" required by the Securities andExchange Commission before IPOs. They have confirmed that a prospectusfor the offering is being developed and should be available nextmonth.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
